menu
    • menu

    Company profile for Novadip Biosciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform. Novadip has developed a robust manufacturing process and distribution platform for its autologous cell therapies. The manufacturing process and supply chain have the capability of rapidly delivering the product candidates globally.The platform is based on a virtuous cycle that occurs between adipose-derived stem ce...
    Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform. Novadip has developed a robust manufacturing process and distribution platform for its autologous cell therapies. The manufacturing process and supply chain have the capability of rapidly delivering the product candidates globally.The platform is based on a virtuous cycle that occurs between adipose-derived stem cells (ASCs) and that develops after adding active particles to the differentiated ASCs resulting in an ECM containing highly bioactive ASCs, with highly specific miRNAs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Novadip BiosciencesBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Watson & Crick Hill, Rue Granbonpré 11, 1435 Mont-Saint-Guibert
    Telephone
    Telephone
    +32 (10) 779 220
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.novadip.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mytos Forms Partnerships with StemSight, Rinri Therapeutics
    Mytos Forms Partnerships with StemSight, Rinri Therapeutics

    03 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-03/mytos-announces-strategic-partnerships-with-stemsight-rinri-therapeutics-and-novadip-to-power-next

    PHARMAWEB
    03 Sep 2025
    Share Share
    Results from Novadip phase 1b/2a trial reveal 88% efficacy
    Results from Novadip phase 1b/2a trial reveal 88% efficacy

    28 Jan 2025

    // PHARMAFILE

    https://pharmafile.com/news/results-from-novadip-phase-1b-2a-trial-reveal-88-efficacy/

    PHARMAFILE
    28 Jan 2025
    Share Share
    Novadip’s NVDX3 Reaches Milestones for IND Approval in Spine Fusion
    Novadip’s NVDX3 Reaches Milestones for IND Approval in Spine Fusion

    20 Nov 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-11-20/novadip-s-nvdx3-reaches-key-milestones-leading-to-ind-approval-from-fda-to-start-phase-2b3-study-in

    PHARMAWEB
    20 Nov 2024
    Share Share
    Novadip Announces First Pediatric Patient Undergoes Implantation with NVD-003
    Novadip Announces First Pediatric Patient Undergoes Implantation with NVD-003

    17 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230517005199/en

    BUSINESSWIRE
    17 May 2023
    Share Share
    Novadip Biosciences SA Appoints Judy Ashworth, MD, as Chief Medical Officer
    Novadip Biosciences SA Appoints Judy Ashworth, MD, as Chief Medical Officer

    27 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221227005137/en

    BUSINESSWIRE
    27 Dec 2022
    Share Share
    Novadip reveals results from severe bone non-union trial
    Novadip reveals results from severe bone non-union trial

    09 Dec 2022

    // PHARMATIMES

    https://www.pharmatimes.com/news/novadip_reveals_results_from_severe_bone_non-union_trial_1482819

    PHARMATIMES
    09 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search